Startups
Neurona Therapeutics
Edit

Neurona Therapeutics

http://www.neuronatherapeutics.com/
Last activity: 03.04.2025
Active
Categories: BioTechBuildingDevelopmentIndustryInformationNetworksPlatformProductWebsite
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
Mentions
26

Overview

Location
United States, California, South San Francisco
Employees
51-200
Total raised
$294.6M
Founded date
2008

Investors 5

Funding Rounds 5

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see
Feb 9, 2024Funding round$120M
Jun 22, 2021Funding round$41.5M
Dec 1, 2015Series A round$23.5M
Dec 24, 2014Funding round$7.6M

Mentions in press and media 26

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Dec 6, 2024Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy SocietySan Francisco, CA, December 6, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for epilepsy and other disorders of the nervous system, today announced positive clinical data from t...
Sep 10, 2024Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy CandidateSAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the California Institute for Re...
Mar 12, 2024Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days
Mar 12, 2024Neurona Therapeutics to Present at Stifel 2024 Virtual CNS DaysSAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nichol...
Mar 7, 2024Neurona Therapeutics Announces Presentation of Updated Clinical Data at the Upcoming American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001
Feb 9, 2024Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics09/02/2024 Nota de prensa YSIOS CAPITAL INVIERTE EN LA SERIE E DE 120 MILLONES DE DÓLARES DE NEURONA THERAPEUTICS Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy su participación en la rond...
Feb 9, 2024Neurona Therapeutics Raises $120M in FundingNeurona Therapeutics, a San Francisco, CA-based clinical-stage biotherapeutics company, raised $120M in funding. The round was led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors,...
Feb 8, 2024Neurona Therapeutics Lands $120M SAN FRANCISCO, CA, Neurona Therapeutics today announced the successful completion of a $120 million financing. >> Click here for more funding data on Neurona Therapeutics >> To export Neurona Therapeutics funding data to PDF...
Feb 8, 2024Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Neurona Therapeutics

When was Neurona Therapeutics founded?

Neurona Therapeutics was founded in 2008.

How much funding has Neurona Therapeutics raised?

Neurona Therapeutics has raised $294.6M in total across 5 funding rounds.

What funding rounds has Neurona Therapeutics raised?

Parsers VC lists 5 funding rounds of Neurona Therapeutics, among them a funding round of $120M on Feb 9, 2024, a funding round of $41.5M on Jun 22, 2021 and a Series A round of $23.5M on Dec 1, 2015.

Who has invested in Neurona Therapeutics?

Parsers VC lists 5 investors of Neurona Therapeutics, among them Ysios Capital, UCB Ventures and The Column Group.

Is Neurona Therapeutics still active?

Yes, Neurona Therapeutics is active; its latest activity on Parsers VC dates from Apr 3, 2025.